{
  "company": {
    "name": "Neutrolis",
    "website": "https://neutrolis.com/",
    "record": "https://startuphistory.org/c/neutrolis.com"
  },
  "status": null,
  "history_since": "2018-08-20T05:41:19.000Z",
  "baseline": {
    "snapshot_id": "477b1b33aec561b792417b5d91d2aea4f3b3418e300a8ec0b45399b124f99008",
    "observed_at": "2018-08-20T05:41:19.000Z",
    "headline": "Untangling Inflammation",
    "description": "Neutrolis is a preclinical drug discovery company focusing on treating inflammatory diseases with unmet needs. Neutrolis uses a proprietary genetic technology platform to identify disease mechanisms a",
    "evidence": "https://web.archive.org/web/20180820054119/https://www.neutrolis.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:49:15.425Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2019-07-21T08:43:01.000Z",
      "variants": [
        {
          "headline": "Untangling Inflammation",
          "subhead": "Neutrolis is a preclinical drug discovery company focusing on treating inflammatory diseases with unmet needs. Neutrolis uses a proprietary genetic technology platform to identify disease mechanisms a",
          "observed_at": "2018-08-20T05:41:19.000Z",
          "evidence": "https://web.archive.org/web/20180820054119/https://www.neutrolis.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Untangling Inflammation",
          "subhead": "Neutrolis is a preclinical drug discovery company focusing on treating inflammatory diseases with unmet needs. Neutrolis uses a proprietary genetic technology platform to identify disease mechanisms a",
          "observed_at": "2019-07-21T08:43:01.000Z",
          "evidence": "https://web.archive.org/web/20190721084301/https://www.neutrolis.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Untangling Inflammation",
      "subhead": "Neutrolis is a preclinical drug discovery company focusing on treating inflammatory diseases with unmet needs. Neutrolis uses a proprietary genetic technology platform to identify disease mechanisms a",
      "from": "2018-08-20T05:41:19.000Z",
      "to": "2019-07-21T08:43:01.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20190721084301/https://www.neutrolis.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2018-08-20T05:41:19.000Z",
          "to": "2019-07-21T08:43:01.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:49:15.425Z",
      "variants": [
        {
          "headline": "Neutrolis - Targeting the Dark Side of DNA",
          "subhead": "Home About Science Pipeline News Contact X COVID-19 Home About Science Pipeline News Contact COVID-19 Targeting the Dark Side of DNA Neutrolis is developing first-in-class therapies for autoimmune and",
          "observed_at": "2021-01-28T04:33:41.000Z",
          "evidence": "https://web.archive.org/web/20210128043341/https://www.neutrolis.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Neutrolis - Targeting the Dark Side of DNA",
          "subhead": "Home About Science Pipeline News Contact X COVID-19 Home About Science Pipeline News Contact COVID-19 Targeting the Dark Side of DNA Neutrolis is developing first-in-class therapies for autoimmune and",
          "observed_at": "2021-08-05T00:44:12.000Z",
          "evidence": "https://web.archive.org/web/20210805004412/https://www.neutrolis.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Neutrolis - Targeting the Dark Side of DNA",
          "subhead": "Home About Science Pipeline News Contact X COVID-19 Home About Science Pipeline News Contact COVID-19 Targeting the Dark Side of DNA Neutrolis is developing first-in-class therapies for autoimmune and",
          "observed_at": "2022-07-05T15:10:15.000Z",
          "evidence": "https://web.archive.org/web/20220705151015/https://www.neutrolis.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Neutrolis - Targeting the Dark Side of DNA",
          "subhead": "Home About Science Pipeline News Contact X COVID-19 Home About Science Pipeline News Contact COVID-19 Targeting the Dark Side of DNA Neutrolis is developing first-in-class therapies for autoimmune and",
          "observed_at": "2023-01-30T04:12:41.000Z",
          "evidence": "https://web.archive.org/web/20230130041241/https://www.neutrolis.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeting the ‍ Dark Side of DNA",
          "subhead": null,
          "observed_at": "2024-07-19T14:27:14.000Z",
          "evidence": "https://web.archive.org/web/20240719142714/https://www.neutrolis.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeting the ‍ Dark Side of DNA",
          "subhead": null,
          "observed_at": "2025-01-01T07:52:03.000Z",
          "evidence": "https://web.archive.org/web/20250101075203/https://www.neutrolis.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeting the ‍ Dark Side of DNA",
          "subhead": null,
          "observed_at": "2026-01-17T15:42:36.000Z",
          "evidence": "https://web.archive.org/web/20260117154236/https://www.neutrolis.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeting the ‍ Dark Side of DNA",
          "subhead": null,
          "observed_at": "2026-07-13T13:26:39.000Z",
          "evidence": "https://web.archive.org/web/20260713132639/https://neutrolis.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeting the ‍ Dark Side of DNA",
          "subhead": null,
          "observed_at": "2026-11-06T17:49:15.425Z",
          "evidence": "https://neutrolis.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Targeting the ‍ Dark Side of DNA",
      "subhead": null,
      "from": "2021-01-28T04:33:41.000Z",
      "to": "2026-11-06T17:49:15.425Z",
      "captures": 9,
      "evidence": "https://neutrolis.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2021-01-28T04:33:41.000Z",
          "to": "2026-11-06T17:49:15.425Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Neutrolis” company record, https://startuphistory.org/c/neutrolis.com"
}